Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

Abstract

BACKGROUND Patients aged 65 years and older represent the majority of patients with metastatic colorectal cancer (mCRC). However, this patient population is often underrepresented in clinical trials and probably undertreated in the clinical practice. METHODS We have analysed the outcomes of 3,187 mCRC patients treated with first-line bevacizumab based on… (More)
DOI: 10.1186/1471-230X-14-53

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Slavek2014EfficacyAS, title={Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry}, author={Lubom{\'i}r Slav{\'i}{\vc}ek and Tom{\'a}s Pavl{\'i}k and Jiř{\'i} Tom{\'a}{\vs}ek and Zbyněk Bortl{\'i}{\vc}ek and Tomas Buchler and Bohuslav Melichar and Rostislav Vyzula and Jana Prausov{\'a} and Jindrich Finek and Ondřej M{\'a}jek and Ladislav Du{\vs}ek}, booktitle={BMC gastroenterology}, year={2014} }